Area | group(2-△CT, x ± s) | |||||||
---|---|---|---|---|---|---|---|---|
normal controls | persistent hr-HPV | CIN1 | CIN1- | CIN2 | CIN3 | cancer | CIN2+ | |
Number of cases | 42 | 31 | 19 | 92 | 54 | 71 | 15 | 140 |
miRNA-21 | 1.96 ± 3.08 | 1.69 ± 2.72 | 3.79 ± 6.17 | 2.25 ± 3.93 | 6.88 ± 11.25 | 5.37 ± 6.25 | 6.87 ± 12.99 | 6.12 ± 9.37 |
miRNA-214 | 1.68 ± 3.40 | 2.20 ± 3.38 | 0.63 ± 1.79 | 1.63 ± 3.20 | 0.31 ± 1.29 | 0.30 ± 1.28 | 0.23 ± 0.31 | 0.29 ± 1.22 |
miRNA-200a | 0.47 ± 0.62 | 0.78 ± 0.96 | 0.21 ± 0.35 | 0.52 ± 0.74 | 0.24 ± 0.41 | 0.22 ± 0.27 | 0.18 ± 0.19 | 0.22 ± 0.32 |
miRNA-34a | 1.62 ± 2.64 | 2.24 ± 2.94 | 0.72 ± 1.39 | 1.64 ± 2.62 | 0.77 ± 1.34 | 0.78 ± 1.78 | 0.45 ± 0.27 | 0.74 ± 1.53 |